Allspring Global Investments’s AtriCure ATRC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-2,074
Closed -$90.8K 2253
2023
Q3
$90.8K Buy
2,074
+497
+32% +$24.2K ﹤0.01% 2036
2023
Q2
$77.8K Sell
1,577
-257
-14% -$11.8K ﹤0.01% 2147
2023
Q1
$76K Sell
1,834
-1,481
-45% -$61.5K ﹤0.01% 2143
2022
Q4
$147K Sell
3,315
-20
-0.6% -$835 ﹤0.01% 1926
2022
Q3
$130K Sell
3,335
-359
-10% -$16.4K ﹤0.01% 1973
2022
Q2
$150K Sell
3,694
-15,079
-80% -$714K ﹤0.01% 1918
2022
Q1
$1.23M Buy
18,773
+1,894
+11% +$123K ﹤0.01% 1760
2021
Q4
$1.17M Buy
+16,879
New +$1.23M ﹤0.01% 1839

Other funds holding ATRC

Allspring Global Investments's ATRC Position: Q4 2023 in Review

Allspring Global Investments sold out of AtriCure (ATRC) in Q4 2023, closing a stake of 2,074 shares — an estimated $90.8K sold.

Allspring Global Investments first reported a position in ATRC in Q4 2021 and held it in 8 quarters. The position peaked at $1.23M in Q1 2022. 233 funds tracked by Wall St. Rank hold ATRC as of Q4 2023.

  • Allspring Global Investments reported no remaining AtriCure position as of Q4 2023 after selling out during the quarter.
  • Allspring Global Investments sold 2,074 AtriCure shares in Q4 2023, an estimated $90.8K.
  • Allspring Global Investments first reported a position in AtriCure in Q4 2021 and held it in 8 quarters.
  • Allspring Global Investments's AtriCure position peaked at $1.23M in Q1 2022.
  • 233 funds tracked by Wall St. Rank held AtriCure as of Q4 2023.

Based on Allspring Global Investments's 13F filing for Q4 2023, filed 25 Jan 2024.